Literature DB >> 29323727

Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol.

Elisa Evangelista1,2,3, Régis Lopez1,2,3, Lucie Barateau1,2,3, Sofiene Chenini1, Adriana Bosco1, Isabelle Jaussent2,3, Yves Dauvilliers1,2,3.   

Abstract

OBJECTIVE: To assess the diagnostic value of extended sleep duration on a controlled 32-hour bed rest protocol in idiopathic hypersomnia (IH).
METHODS: One hundred sixteen patients with high suspicion of IH (37 clear-cut IH according to multiple sleep latency test criteria and 79 probable IH), 32 with hypersomnolence associated with a comorbid disorder (non-IH), and 21 controls underwent polysomnography, modified sleep latency tests, and a 32-hour bed rest protocol. Receiver operating characteristic curves were used to find optimal total sleep time (TST) cutoff values on various periods that discriminate patients from controls.
RESULTS: TST was longer in patients with clear-cut IH than other groups (probable IH, non-IH, and controls) and in patients with probable IH than non-IH and controls. The TST cutoff best discriminating clear-cut IH and controls was 19 hours for the 32-hour recording (sensitivity = 91.9%, specificity = 85.7%) and 12 hours (100%, 85.7%) for the first 24 hours. The 19-hour cutoff displayed a specificity and sensitivity of 91.9% and 81.2% between IH and non-IH patients. Patients with IH above the 19-hour cutoff were overweight, had more sleep inertia, and had higher TST on all periods compared to patients below 19 hours, whereas no differences were found for the 12-hour cutoff. An inverse correlation was found between the mean sleep latency and TST during 32-hour recording in IH patients.
INTERPRETATION: In standardized and controlled stringent conditions, the optimal cutoff best discriminating patients from controls was 19 hours over 32 hours, allowing a clear-cut phenotypical characterization of major interest for research purposes. Sleepier patients on the multiple sleep latency test were also the more severe in terms of extended sleep. Ann Neurol 2018;83:235-247.
© 2018 American Neurological Association.

Entities:  

Mesh:

Year:  2018        PMID: 29323727     DOI: 10.1002/ana.25141

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Establishing the objective sleep phenotype in hypersomnolence disorder with and without comorbid major depression.

Authors:  David T Plante; Jesse D Cook; Leonardo S Barbosa; Michael R Goldstein; Michael L Prairie; Richard F Smith; Brady A Riedner
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

2.  Observation and Interview-based Diurnal Sleepiness Inventory for measurement of sleepiness in patients referred for narcolepsy or idiopathic hypersomnia.

Authors:  Laure Peter-Derex; Fabien Subtil; Guillaume Lemaitre; François Ricordeau; Hélène Bastuji; Agathe Bridoux; Fannie Onen; S-Hakki Onen
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

3.  Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and their consequences in idiopathic hypersomnia.

Authors:  Anna Laura Rassu; Elisa Evangelista; Lucie Barateau; Sofiene Chenini; Régis Lopez; Isabelle Jaussent; Yves Dauvilliers
Journal:  J Clin Sleep Med       Date:  2022-02-01       Impact factor: 4.062

4.  The growing toolkit for evaluation of central disorders of hypersomnolence.

Authors:  David T Plante
Journal:  Sleep       Date:  2022-06-13       Impact factor: 6.313

5.  Comorbid parasomnias in narcolepsy and idiopathic hypersomnia: more REM than NREM parasomnias.

Authors:  Smaranda Leu-Semenescu; Jean-Baptiste Maranci; Régis Lopez; Xavier Drouot; Pauline Dodet; Ana Gales; Elisabeth Groos; Lucie Barateau; Patricia Franco; Michel Lecendreux; Yves Dauvilliers; Isabelle Arnulf
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

6.  Multimodal assessment increases objective identification of hypersomnolence in patients referred for multiple sleep latency testing.

Authors:  David T Plante; Jesse D Cook; Michael L Prairie
Journal:  J Clin Sleep Med       Date:  2020-08-15       Impact factor: 4.062

Review 7.  Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Authors:  Lynn Marie Trotti; Isabelle Arnulf
Journal:  Neurotherapeutics       Date:  2021-01       Impact factor: 7.620

8.  Data-Driven Phenotyping of Central Disorders of Hypersomnolence With Unsupervised Clustering.

Authors:  Jari K Gool; Zhongxing Zhang; Martijn S S L Oei; Stephanie Mathias; Yves Dauvilliers; Geert Mayer; Giuseppe Plazzi; Rafael Del Rio-Villegas; Joan Santamaria Cano; Karel Šonka; Markku Partinen; Sebastiaan Overeem; Rosa Peraita-Adrados; Raphael Heinzer; Antonio Martins da Silva; Birgit Högl; Aleksandra Wierzbicka; Anna Heidbreder; Eva Feketeova; Mauro Manconi; Jitka Bušková; Francesca Canellas; Claudio L Bassetti; Lucie Barateau; Fabio Pizza; Markus H Schmidt; Rolf Fronczek; Ramin Khatami; Gert Jan Lammers
Journal:  Neurology       Date:  2022-04-18       Impact factor: 11.800

9.  Cerebrospinal fluid monoamine levels in central disorders of hypersomnolence.

Authors:  Lucie Barateau; Isabelle Jaussent; Julien Roeser; Claudio Ciardiello; Thomas S Kilduff; Yves Dauvilliers
Journal:  Sleep       Date:  2021-07-09       Impact factor: 6.313

Review 10.  Central Disorders of Hypersomnolence.

Authors:  Lynn Marie Trotti
Journal:  Continuum (Minneap Minn)       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.